News & Publications

News

Deals & Cases

Sale of SFL Group

6 March 2022 – The two former shareholders, Shayesteh Fürst-Ladani und Walter Fürst, have sold 100% of the shares in all SFL group companies with their registered seats in Switzerland (SFL Regulatory Affairs & Scientific Communication GmbH und SFL Pharma GmbH), Germany (SFL Pharmaceuticals Deutschland GmbH), Austria (SFL Regulatory Services GmbH), and the UK (SFL Regulatory Affairs Consulting Ltd) to US-based clinical research organization (CRO) Veristat.

SFL Group is a leading consulting firm providing integrated solutions to pharmaceutical, biotech, and Medtech companies in the areas of drug development, regulatory affairs, and clinical trials, as well as combined drug-medicine products.

Walder Wyss has advised as lead transaction counsel the two former shareholders, Shayesteh Fürst-Ladani und Walter Fürst, on the Swiss law aspects of the transaction. The team included Stefan Knobloch (Partner, Corporate/M&A), Dario Galli (Associate, Corporate/M&A), and Marina Beeler (Junior Associate, Corporate/M&A).

Technically necessary cookies

Essential technical cookies are necessary for the flawless functioning of our website and cannot be disabled.
Cookies for statistics

Analytical cookies enable us to count visits and traffic sources, allowing us to measure and enhance the performance of our website. They assist us in answering questions such as which pages are the most popular, which are the least used, and how visitors navigate the website. All information collected by these cookies is aggregated and therefore anonymous.
Marketing cookies may be set by our advertising partners on our website. These companies can use them to create a profile of your interests and display relevant advertisements on other websites. They operate by uniquely identifying your browser and device. By activating these cookies, you acknowledge and consent to the information collected by such cookies being sent to providers outside of Switzerland and the EU, including countries with (from the perspective of Swiss data protection law) inadequate data protection (e.g., the United States, Singapore, and Taiwan). You also acknowledge that data transmitted abroad is no longer protected by Swiss law, and foreign laws as well as regulatory orders may require the disclosure of this data to authorities and other third parties.

Marketing cookies may be set by our advertising partners on our website. These companies can use them to create a profile of your interests and display relevant advertisements on other websites. They operate by uniquely identifying your browser and device. By activating these cookies, you acknowledge and consent to the information collected by such cookies being sent to providers outside of Switzerland and the EU, including countries with (from the perspective of Swiss data protection law) inadequate data protection (e.g., the United States, Singapore, and Taiwan). You also acknowledge that data transmitted abroad is no longer protected by Swiss law, and foreign laws as well as regulatory orders may require the disclosure of this data to authorities and other third parties.